David Krempa
Chief Business Officer · 6 filings · Latest: Oct 6, 2026
Eton Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ETON | David Krempa | Chief Business Officer | Oct 6, 2026 | Sale | $55.07 | 4,166 | $229.4K | 43,381 | |
ETON | David Krempa | Chief Business Officer | Oct 2, 2026 | Option Exercise | — | 10,522 | — | 47,547 | |
ETON | Krempa David | — | Oct 6, 2026 | Proposed Sale | $55.07 | 4,166 | $229.4K | — | |
ETON | David Krempa | Chief Business Officer | Aug 24, 2026 | Sale | $65.07 | 25,000 | $1.6M | 37,025 | |
ETON | David Krempa | Chief Business Officer | Aug 24, 2026 | Option Exercise | $7.31 | 25,000 | $182.8K | 62,025 | |
ETON | Krempa David | — | Aug 24, 2026 | Proposed Sale | $65.07 | 25,000 | $1.6M | — | |
ETON | David Krempa | Chief Business Officer | Jul 12, 2026 | Option Exercise | — | 10,000 | — | 37,025 | |
ETON | David Krempa | Chief Business Officer | May 27, 2026 | Sale | $31.47 | 19,679 | $619.4K | 25,249 | |
ETON | David Krempa | Chief Business Officer | May 27, 2026 | Option Exercise | $2.18 | 19,679 | $42.9K | 44,928 | |
ETON | David Krempa | Chief Business Officer | May 26, 2026 | Sale | $31.49 | 37,524 | $1.2M | 25,249 | |
ETON | David Krempa | Chief Business Officer | May 26, 2026 | Option Exercise | $1.38 | 37,524 | $51.7K | 62,773 | |
ETON | David Krempa | Chief Business Officer | May 22, 2026 | Sale | $33.39 | 42,797 | $1.4M | 25,249 | |
ETON | David Krempa | Chief Business Officer | May 22, 2026 | Option Exercise | $3.58 | 30,591 | $109.5K | 68,046 | |
ETON | Krempa David | — | May 22, 2026 | Proposed Sale | $35.00 | 100,000 | $3.5M | — | |
ETON | Krempa David | — | Jan 14, 2026 | Proposed Sale | $15.62 | 1,942 | $30.3K | — | |
ETON | Krempa David | — | Dec 12, 2025 | Proposed Sale | $16.88 | 7,545 | $127.4K | — | |
ETON | Krempa David | — | Jun 12, 2025 | Proposed Sale | $15.00 | 40,000 | $600.0K | — |